Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Work In Process (2016 - 2026)

Orthofix Medical has reported Work In Process over the past 16 years, most recently at $65.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Work In Process rose 14.84% year-over-year to $65.2 million, compared with a TTM value of $65.2 million through Mar 2026, up 14.84%, and an annual FY2025 reading of $63.3 million, up 11.13% over the prior year.
  • Work In Process came in at $65.2 million for Q1 2026, up from $63.3 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $65.2 million in Q1 2026 to a low of $14.5 million in Q1 2022.
  • Median Work In Process over the past 5 years was $56.8 million (2025), compared with a mean of $48.6 million.
  • The sharpest move saw Work In Process decreased 5.48% in 2022, then surged 303.9% in 2023.
  • Over 5 years, Work In Process stood at $19.2 million in 2022, then soared by 178.08% to $53.5 million in 2023, then grew by 6.37% to $56.9 million in 2024, then rose by 11.13% to $63.3 million in 2025, then rose by 3.07% to $65.2 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Work In Process are $65.2 million (Q1 2026), $63.3 million (Q4 2025), and $61.0 million (Q3 2025).